The ultimate effect is G1 cell cycle arrest and senescence; however, HPVs have evolved to target pRB for ubiquitin-dependent proteasomal degradation, which is why p16INK4A upregulation in HPV-positive cancer cells does not inhibit proliferation [332,333,334]. The gene discussed is RB1; the disease is cancer.